ArticleOncology letters2016

BCL9, a coactivator for Wnt/β-catenin transcription, is targeted by miR-30c and is associated with prostate cancer progression.

Xiao-Hui Ling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.